» Articles » PMID: 8190093

Signal Transduction by the Cloned Glucagon-like Peptide-1 Receptor: Comparison with Signaling by the Endogenous Receptors of Beta Cell Lines

Overview
Journal Mol Pharmacol
Date 1994 May 1
PMID 8190093
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone that potentiates glucose-induced insulin secretion by pancreatic beta cells. The mechanisms of interaction between GLP-1 and glucose signaling pathways are not well understood. Here we studied the coupling of the cloned GLP-1 receptor, expressed in fibroblasts or in COS cells, to intracellular second messengers and compared this signaling with that of the endogenous receptor expressed in insulinoma cell lines. Binding of GLP-1 to the cloned receptor stimulated formation of cAMP with the same dose dependence and similar kinetics, compared with the endogenous receptor of insulinoma cells. Compared with forskolin-induced cAMP accumulation, that induced by GLP-1 proceeded with the same initial kinetics but rapidly reached a plateau, suggesting fast desensitization of the receptor. Coupling to the phospholipase C pathway was assessed by measuring inositol phosphate production and variations in the intracellular calcium concentration. No GLP-1-induced production of inositol phosphates could be measured in the different cell types studied. A rise in the intracellular calcium concentration was nevertheless observed in transfected COS cells but was much smaller than that observed in response to norepinephrine in cells also expressing the alpha 1B-adrenergic receptor. Importantly, no such increase in the intracellular calcium concentration could be observed in transfected fibroblasts or insulinoma cells, which, however, responded well to thrombin or carbachol, respectively. Together, our data show that interaction between GLP-1 and glucose signaling pathways in beta cells may be mediated uniquely by an increase in the intracellular cAMP concentration, with the consequent activation of protein kinase A and phosphorylation of elements of the glucose-sensing apparatus or of the insulin granule exocytic machinery.

Citing Articles

Activation of the renal GLP-1R leads to expression of in the renal vascular tree.

Bjornholm K, Ougaard M, Skovsted G, Knudsen L, Pyke C Endocrinol Diabetes Metab. 2021; 4(3):e00234.

PMID: 34277961 PMC: 8279630. DOI: 10.1002/edm2.234.


GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor.

Fusco J, Xiao X, Prasadan K, Sheng Q, Chen C, Ming Y Sci Rep. 2017; 7(1):9100.

PMID: 28831150 PMC: 5567347. DOI: 10.1038/s41598-017-09898-4.


The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer of -Cell Proliferation.

Abu-Farha M, Madhoun A, Abubaker J J Diabetes Res. 2016; 2016:4860595.

PMID: 27672665 PMC: 5031879. DOI: 10.1155/2016/4860595.


Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

de Graaf C, Donnelly D, Wootten D, Lau J, Sexton P, Miller L Pharmacol Rev. 2016; 68(4):954-1013.

PMID: 27630114 PMC: 5050443. DOI: 10.1124/pr.115.011395.


The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.

Andreozzi F, Raciti G, Nigro C, Mannino G, Procopio T, Davalli A J Transl Med. 2016; 14(1):229.

PMID: 27473212 PMC: 4967343. DOI: 10.1186/s12967-016-0985-7.